Vestal Point Capital, LP Purchases in Q3 2025

Vestal Point Capital, LP

  • $2.21 Trillion
  • Q3 2025
Stock Shares change Price Range Shares Held Trade History
Abivax Sa
1M
New
N/A
1M $84.9B
ASND
Ascendis Pharma A/S

Healthcare
400K
+ 200.0%
$163.32 - $205.91 $65.3M - $82.4M
600K $119B
BDX
Becton Dickinson & CO

Healthcare
300K
+ 1200.0%
$172.41 - $199.66 $51.7M - $59.9M
325K $60.8B
RGEN
Repligen Corp

Healthcare
400K
New
$111.43 - $134.0 $44.6M - $53.6M
400K $53.5B
IONS
Ionis Pharmaceuticals Inc

Healthcare
575K
+ 115.0%
$39.94 - $65.42 $23M - $37.6M
1.08M $70.3B
DXCM
Dexcom Inc

Healthcare
650K
New
$66.46 - $89.53 $43.2M - $58.2M
650K $43.7B
GMED
Globus Medical Inc

Healthcare
750K
+ 150.0%
$51.89 - $62.79 $38.9M - $47.1M
1.25M $71.6B
BIIB
Biogen Inc.

Healthcare
275K
New
$122.68 - $148.84 $33.7M - $40.9M
275K $38.5B
ALC
Alcon Inc

Healthcare
575K
+ 109.52%
$73.24 - $92.22 $42.1M - $53M
1.1M $82B
Bicara Therapeutics Inc
100K
+ 2.0%
N/A
5.1M $80.5B
DYN
Dyne Therapeutics, Inc.

Healthcare
2.05M
+ 281.44%
$8.18 - $14.22 $16.7M - $29.1M
2.78M $35.1B
Disc Medicine Inc
360K
+ 257.14%
N/A
500K $33B
BLTE
Belite Bio, Inc

Healthcare
313K
New
$56.81 - $74.0 $17.8M - $23.1M
313K $23.1B
RARE
Ultragenyx Pharmaceutical Inc.

Healthcare
750K
New
$26.31 - $41.44 $19.7M - $31.1M
750K $22.6B
IMTX
Immatics N.V.

Healthcare
100K
+ 1.6%
$5.09 - $8.52 $509K - $852K
6.35M $54.1B
DHR
Danaher Corp

Healthcare
100K
+ 200.0%
$181.46 - $212.2 $18.1M - $21.2M
150K $29.7B
Enliven Therapeutics Inc
910K
+ 364.0%
N/A
1.16M $23.7B
AXSM
Axsome Therapeutics, Inc.

Healthcare
150K
New
$100.39 - $129.29 $15.1M - $19.4M
150K $18.2B
BMRN
Biomarin Pharmaceutical Inc

Healthcare
330K
+ 66.0%
$52.62 - $61.93 $17.4M - $20.4M
830K $45B
Apogee Therapeutics Inc
425K
New
N/A
425K $16.9B
Zymeworks Inc
615K
+ 53.48%
N/A
1.77M $30.1B
REGN
Regeneron Pharmaceuticals, Inc.

Healthcare
25K
New
$534.91 - $598.71 $13.4M - $15M
25K $14.1B
NUVL
Nuvalent, Inc.

Healthcare
25K
+ 2.33%
$72.16 - $86.48 $1.8M - $2.16M
1.1M $95.1B
ATXS
Astria Therapeutics, Inc.

Healthcare
434K
+ 9.6%
$5.43 - $7.6 $2.36M - $3.3M
4.96M $36.1B
TSHA
Taysha Gene Therapies, Inc.

Healthcare
2.5M
+ 83.33%
$2.34 - $3.29 $5.85M - $8.23M
5.5M $18B
Solid Biosciences Inc
1.47M
+ 97.67%
N/A
2.98M $18.4B
INSP
Inspire Medical Systems, Inc.

Healthcare
135K
New
$74.2 - $139.25 $10M - $18.8M
135K $10B
ABT
Abbott Laboratories

Healthcare
75K
+ 42.86%
$120.51 - $136.62 $9.04M - $10.2M
250K $33.5B
NRIX
Nurix Therapeutics, Inc.

Healthcare
1.48M
+ 73.75%
$8.24 - $13.18 $12.2M - $19.4M
3.48M $32.1B
Lexeo Therapeutics Inc
21.8K
+ 0.68%
N/A
3.25M $21.6B
Cg Oncology Inc
175K
New
N/A
175K $7.05B
Tvardi Therapeutics Inc
167K
New
N/A
167K $6.51B
GLUE
Monte Rosa Therapeutics, Inc.

Healthcare
800K
New
$4.19 - $7.49 $3.35M - $5.99M
800K $5.93B
Gsk PLC
125K
New
N/A
125K $5.4B
NVCR
Novo Cure LTD

Healthcare
400K
New
$10.9 - $18.46 $4.36M - $7.38M
400K $5.17B
AGIO
Agios Pharmaceuticals, Inc.

Healthcare
127K
New
$34.37 - $40.61 $4.36M - $5.16M
127K $5.1B
APLT
Applied Therapeutics Inc.

Healthcare
2.75M
+ 23.91%
$0.32 - $1.24 $880K - $3.41M
14.3M $8.62B
LNTH
Lantheus Holdings, Inc.

Healthcare
120K
+ 240.0%
$50.11 - $83.83 $6.01M - $10.1M
170K $8.72B
MYGN
Myriad Genetics Inc

Healthcare
600K
New
$3.84 - $7.84 $2.3M - $4.7M
600K $4.34B
ESTA
Establishment Labs Holdings Inc.

Healthcare
100K
New
$33.62 - $46.11 $3.36M - $4.61M
100K $4.1B
KOD
Kodiak Sciences Inc.

Healthcare
250K
New
$3.68 - $16.37 $920K - $4.09M
250K $4.09B
Beta Bionics Inc
50K
+ 9.09%
N/A
600K $11.9B
RCUS
Arcus Biosciences, Inc.

Healthcare
250K
New
$8.22 - $13.6 $2.06M - $3.4M
250K $3.4B
Passage Bio Inc
305K
New
N/A
305K $2.45B
ARQT
Arcutis Biotherapeutics, Inc.

Healthcare
105K
+ 110.53%
$13.39 - $18.85 $1.41M - $1.98M
200K $3.77B
VTYX
Ventyx Biosciences, Inc.

Healthcare
50K
+ 2.5%
$2.02 - $3.27 $101K - $164K
2.05M $6.38B
ALEC
Alector, Inc.

Healthcare
3.01K
+ 0.31%
$1.42 - $3.18 $4.27K - $9.57K
980K $2.9B
LUNG
Pulmonx Corp

Healthcare
830K
New
$1.51 - $3.78 $1.25M - $3.14M
830K $1.34B
Traws Pharma Inc
200
+ 0.13%
N/A
150K $278M
Activity Summary
Buys All Purchases 50 New Holdings 23 Increased Positions 27 Sells All Sells 21 Reductions 21 Sold out 0 Options Calls 0 Puts 1
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email